COMP <GO>
INCY vs IQV // EV/EBITDA & P/E VALUATION
Incyte Corp. (NASDAQ) VS. IQVIA Holdings Inc. (NYSE) • 15-METRIC TALLY: INCY 9
— IQV 3
▲ EV/EBITDA & P/E VALUATION LEADER: INCY
LAST: $120.39 (+3.07%) • MKT CAP: $23.68B
valuation
12.5x
LAST: $267.33 (-2.81%) • MKT CAP: $45.33B
valuation
20.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INCY VS. IQV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INCY | IQV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 42.40% | 9.40% | +33.00 | INCY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.5x | 20.4x | -7.90 | INCY | /valuation <GO> |
| Free Cash Flow Yield | 4.99% | 4.24% | +0.75 | INCY | /fcf-yield <GO> |
| Operating Margin | 29.50% | 13.40% | +16.10 | INCY | /operating-margins <GO> |
| Net Profit Margin | 25.00% | 8.30% | +16.70 | INCY | /net-margins <GO> |
| Revenue Growth (YoY) | 21.20% | 5.90% | +15.30 | INCY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.04 | 2.22 | +7.82 | INCY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | INCY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 55.7 | -5.70 | IQV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.16 | -0.15 | IQV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 31.0x | -15.50 | INCY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $23.68B | $45.33B | -$21.65B | IQV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INCY REV | IQV REV | INCY GROSS % | IQV GROSS % | INCY FCF | IQV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.14B | $16.31B | 92.8% | — | $1.18B | $1.92B |
| FY 2024 | $4.24B | $15.40B | 92.6% | — | $144.5M | $2.02B |
| FY 2023 | $3.70B | $14.98B | — | — | $330.2M | $1.47B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INCY // BETA 1.01
IQV // BETA 1.16